TBI: Definition, Uses, and Clinical Overview

TBI Introduction (What it is)

TBI most commonly means toe-brachial index in cardiovascular medicine.
It is a ratio comparing blood pressure at the toe to blood pressure in the arm.
Clinicians use TBI to help evaluate circulation in the legs and feet, especially for peripheral artery disease.
It is often discussed alongside the ankle-brachial index (ABI), particularly when ABI may be less reliable.

Why TBI used (Purpose / benefits)

TBI is used to help assess blood flow to the lower extremities, with particular attention to the small arteries supplying the toes and forefoot. The main clinical problem it addresses is identifying and characterizing peripheral artery disease (PAD)—a condition where arteries supplying the legs become narrowed or blocked, most often due to atherosclerosis (plaque buildup).

Key purposes and potential benefits include:

• Improved detection of PAD when ABI is limited. In some people—especially those with long-standing diabetes or chronic kidney disease—arteries at the ankle can become stiff and difficult to compress, which can make ABI readings misleading. Toe arteries are often less affected by this type of stiffness, so TBI may better reflect true limb perfusion in those situations.
• Risk stratification and clinical planning. TBI results can support decisions about how urgently to evaluate symptoms (like exertional leg pain) or signs (like slow-healing foot wounds), and what additional tests may be helpful.
• Baseline and follow-up comparison. Because TBI is a numeric measurement, clinicians may use it to compare perfusion over time, such as before and after an intervention, or during longitudinal PAD monitoring.
• Wound and limb perfusion assessment. Toe-level measurements are commonly referenced when clinicians are trying to understand whether blood flow is sufficient to support tissue health in the foot.

TBI is not a standalone diagnosis. It is typically interpreted together with symptoms, physical exam findings (like pulses), and other vascular tests when needed.

Clinical context (When cardiologists or cardiovascular clinicians use it)

Common scenarios where TBI may be used include:

• Suspected peripheral artery disease with leg symptoms (for example, exertional calf or thigh discomfort).
• Diabetes or chronic kidney disease, when ankle arteries may be less compressible and ABI may be difficult to interpret.
• Evaluation of foot ulcers, slow-healing wounds, or tissue changes where blood flow is a concern.
• PAD evaluation in older adults with signs of diffuse atherosclerosis (for example, coexisting coronary or carotid artery disease).
• Follow-up after revascularization (endovascular or surgical) as part of a broader perfusion assessment plan.
• When pedal pulses are difficult to palpate, and clinicians want an objective, toe-level perfusion measure.

Contraindications / when it’s NOT ideal

TBI is noninvasive, but it is not ideal or feasible in every situation. Situations where TBI may be limited, deferred, or replaced by another approach can include:

• Toe amputation or anatomy that prevents correct cuff placement or sensor positioning.
• Open wounds, infection, significant ulceration, or recent surgery on the toe where cuff inflation could disrupt tissue or cause pain.
• Severe toe pain or hypersensitivity that makes cuff inflation intolerable.
• Marked edema, bandaging, casts, or deformity that interferes with accurate cuff placement or sensor readings.
• Vasospastic conditions (for example, cold-induced vasoconstriction) that can temporarily reduce toe perfusion and complicate interpretation; clinical teams often try to optimize room temperature and patient warming when appropriate.
• Significant movement, tremor, or inability to remain still, which can reduce signal quality for some devices.
• Situations where clinicians need anatomic detail (exact location and severity of a blockage); TBI is physiologic and does not map arteries. In those cases, duplex ultrasound, CT angiography, MR angiography, or catheter angiography may be more informative.

Which alternative is chosen varies by clinician and case.

How it works (Mechanism / physiology)

At a high level, TBI measures how much systolic blood pressure reaches the toe compared with the arm.

• Physiologic principle: Blood pressure generally falls across a significant arterial narrowing. If arteries in the leg are narrowed, the pressure measured downstream (at the toe) may be reduced relative to the arm.
• What is measured:
• Brachial systolic pressure (upper arm).
• Toe systolic pressure (big toe or another toe, depending on local protocol and anatomy).
• TBI is calculated as: toe systolic pressure ÷ brachial systolic pressure.
• Relevant anatomy:
• The brachial artery reflects central arterial pressure delivered from the heart through the aorta and upper-extremity arteries.
• Toe pressure reflects flow through the aorto-iliac, femoral, popliteal, tibial/peroneal arteries, and into the digital arteries of the foot.
• How toe pressure is detected: Many labs use a small toe cuff plus a sensor that detects return of blood flow during cuff deflation. Depending on equipment, the sensor may use photoplethysmography (a light-based signal) or Doppler-based methods. Specific hardware and algorithms vary by material and manufacturer.
• Clinical interpretation: A lower TBI generally suggests reduced perfusion to the toes and may support a diagnosis of PAD, but exact cutoffs and reporting language vary by clinician and vascular laboratory. Interpretation also depends on temperature, patient positioning, and whether pressures are measured at rest or after exertion.
• Time course and reversibility: TBI is a snapshot of perfusion at the time of testing. It can change with progression of atherosclerosis, acute changes in vascular tone, or after treatments that improve blood flow.

If a patient has arrhythmias, severe vasoconstriction, or technical challenges, measurements may be less reproducible, and clinicians may emphasize trends and complementary tests.

TBI Procedure overview (How it’s applied)

TBI is a test, not a treatment. A typical workflow is:

1. Evaluation/exam
   – Review of symptoms, vascular history, and relevant comorbidities (for example, diabetes, kidney disease, smoking history).
   – Brief vascular exam (skin temperature, capillary refill, pulses, and any wounds).

2. Preparation
   – Patient rests supine (lying flat) for a short period to stabilize pressures.
   – Shoes and socks are removed; toes are inspected and positioned.
   – The room may be kept warm to reduce cold-related vasoconstriction when feasible.

3. Intervention/testing
   – Arm pressure is measured at one or both brachial arteries.
   – A small cuff is placed around the toe, and a sensor is positioned to detect the pulse signal.
   – The cuff inflates briefly and then deflates while the device detects the systolic pressure at which flow returns.

4. Immediate checks
   – Measurements may be repeated to confirm signal quality and consistency.
   – Left and right sides are typically recorded separately.

5. Follow-up
   – Results are documented with the broader vascular assessment (often alongside ABI, pulse volume recordings, or Doppler waveforms).
   – Next steps depend on the clinical question, symptoms, and overall risk profile, and vary by clinician and case.

In many settings, TBI is performed in a vascular lab, cardiology clinic, or multidisciplinary limb-preservation program.

Types / variations

TBI testing can differ in technique and clinical framing. Common variations include:

• Resting TBI vs post-exercise assessment: Most TBIs are done at rest. In some settings, clinicians may incorporate exercise testing to evaluate exertional symptoms, though this is more common with ABI-based protocols.
• Left vs right TBI: Each leg is assessed independently, which can help identify asymmetric disease.
• TBI with toe pressure reporting: Many reports include both the ratio (TBI) and the absolute toe systolic pressure, since absolute pressure is often referenced when evaluating tissue perfusion in the foot. How strongly clinicians weigh each value varies by clinician and case.
• Measurement technology differences:
• Photoplethysmography-based sensors
• Doppler-based detection

• Different cuff sizes and signal-processing approaches
  Results can vary somewhat across devices and labs, so many clinicians focus on consistent technique within a given lab when trending results.

• Combined physiologic testing bundles: TBI may be paired with ABI, segmental limb pressures, pulse volume recordings, and Doppler waveform analysis to create a more complete physiologic picture.

Pros and cons

Pros:

• Noninvasive and typically quick to perform.
• Useful when ABI may be less reliable due to noncompressible ankle arteries.
• Provides toe-level information relevant to foot perfusion and tissue health.
• Can be repeated over time for comparison within the same lab approach.
• Helps support PAD assessment as part of a broader cardiovascular risk evaluation.
• Often complements clinical exam findings when pulses are difficult to assess.

Cons:

• Does not show the location or anatomy of arterial narrowing; it is not an imaging test.
• Results can be affected by cold temperature, vasoconstriction, movement, or poor signal quality.
• Not feasible in some patients due to toe wounds, bandages, deformity, or amputation.
• Interpretation thresholds and reporting practices can vary by lab and clinician.
• May be less informative in certain microvascular or non-atherosclerotic conditions where toe perfusion changes do not reflect large-artery PAD alone.
• Like other pressure-based tests, it may be influenced by systemic blood pressure changes during the visit.

Aftercare & longevity

Because TBI is a diagnostic measurement, “aftercare” usually refers to what happens after results are reviewed and how the information is used over time.

General factors that influence how clinicians use TBI results and how meaningful trends are include:

• Severity and distribution of vascular disease: More diffuse PAD can produce more consistently reduced toe perfusion; localized disease may require additional anatomic testing to define.
• Coexisting conditions: Diabetes, chronic kidney disease, anemia, heart failure, and systemic inflammatory conditions can influence symptoms, wound risk, and test interpretation.
• Temperature and testing conditions: Toe pressures can be sensitive to ambient temperature and sympathetic tone; consistent lab technique improves comparability.
• Medication and hemodynamic context: Blood pressure at the time of testing affects the brachial denominator and overall physiologic state. Clinicians generally interpret TBI within the broader vital-sign context.
• Follow-up strategy: Some patients have TBI repeated to monitor change after an intervention or during surveillance. The timing and frequency vary by clinician and case.
• Overall cardiovascular risk management: PAD often coexists with coronary and cerebrovascular disease. In practice, TBI results may prompt broader risk discussion and coordination among cardiology, vascular medicine, podiatry, and wound care teams, depending on the presentation.

TBI values are not “permanent.” They can change with disease progression, treatment, or acute physiologic conditions.

Alternatives / comparisons

TBI is one tool among several used to evaluate leg and foot circulation. High-level comparisons include:

• ABI (ankle-brachial index):
  ABI is widely used as a first-line PAD screening test. TBI is often considered when ABI is normal but symptoms persist, or when ABI appears falsely elevated due to noncompressible ankle arteries. These tests are complementary rather than competing.

• Duplex ultrasound:
  Duplex provides both anatomy and flow information in specific arteries and can help localize stenosis or occlusion. It is more operator-dependent and time-intensive than TBI but offers greater detail.

• Pulse volume recordings (PVR) / segmental pressures:
  These physiologic tests evaluate blood volume changes and pressure gradients at multiple leg levels, helping suggest where disease may be located. They are often performed in the same visit as TBI.

• CT angiography (CTA) or MR angiography (MRA):
  These imaging tests map arterial anatomy and can help plan interventions. They typically involve more resources than TBI, and the choice depends on clinical need and patient factors (for example, kidney function or contrast considerations).

• Catheter angiography:
  An invasive imaging approach that can diagnose and potentially treat disease in the same session. It is generally reserved for cases where detailed anatomy is needed for decision-making or planned revascularization.

• Transcutaneous oxygen measurement (TcPO₂) or skin perfusion pressure:
  These assess tissue oxygenation/perfusion and are sometimes used in wound-focused evaluations. Availability and interpretation practices vary.

Selection among these options varies by clinician and case, and many patients undergo more than one test to answer different clinical questions.

TBI Common questions (FAQ)

Q: Is TBI the same as traumatic brain injury?
In cardiovascular medicine, TBI most often refers to the toe-brachial index, a circulation test. In neurology and emergency medicine, “TBI” commonly means traumatic brain injury. The meaning depends on the clinical context.

Q: What does a TBI test feel like—does it hurt?
Most people feel brief pressure from cuff inflation on the arm and toe. Some experience discomfort, especially if the toe is sensitive, cold, or already painful from a wound. If pain limits testing, clinicians may consider alternative assessments.

Q: How long does a TBI test take?
The measurement itself is usually brief, but the full appointment may take longer due to resting time, repeat measurements, and additional vascular tests performed in the same session. Timing varies by facility workflow and the extent of testing ordered.

Q: What does a “low” TBI mean?
A reduced TBI generally suggests lower blood pressure reaching the toe compared with the arm, which can be consistent with PAD. Clinicians interpret it alongside symptoms, exam findings, and other vascular studies, and specific cutoffs may differ across labs and clinicians.

Q: Can TBI results be normal even if I have leg symptoms?
Yes. Leg symptoms can come from multiple causes, including musculoskeletal, neurologic, or venous conditions. Some people may also have early or localized vascular disease that is better detected with other physiologic tests or imaging.

Q: Does TBI replace ultrasound or angiography?
No. TBI is a physiologic screening/assessment tool and does not show where an artery is narrowed. Ultrasound or angiography may be used when clinicians need anatomic detail or are planning an intervention.

Q: Will I need to stay in the hospital for a TBI test?
TBI is commonly performed as an outpatient test. Hospital-based testing may occur if a person is already hospitalized for another reason (for example, evaluation of a severe foot wound), but the test itself does not typically require admission.

Q: Are there activity restrictions after a TBI test?
Usually there are no special restrictions because the test is noninvasive. If the test was performed in the setting of a painful wound or severe symptoms, any activity guidance generally relates to the underlying condition rather than the TBI measurement itself.

Q: How long do TBI results “last”?
TBI reflects circulation at the time of testing. Results may remain similar for a period in stable disease, but they can change with progression, treatment, or changes in vascular tone and overall blood pressure. Clinicians may repeat testing when symptoms change or to follow known PAD.

Q: How much does a TBI test cost?
Cost varies widely by region, facility, insurance coverage, and whether other vascular studies are performed at the same visit. Billing can also differ based on how the test is bundled and coded by the clinic or vascular laboratory.